Background: This research aimed to study the role of ezrin, CD44, and VEGF in invasion, metastasis, recurrence, and prognosis of giant cell tumor of bone (GCTB) and its association with the clinical and pathological features of GCTB.
Methods: Expression status of ezrin, CD44, and VEGF in 80 GCTB tissues and its adjacent noncancerous tissue samples were measured with immunohistochemical and Elivison staining. Their correlation with the clinical and pathologic factors was statistically analyzed by chi-square test.
Results: The expression status of ezrin, CD44, and VEGF were significantly higher in GCTB tissue samples than in its adjacent noncancerous tissue samples and in GCTB at Campanacci stage III than in Campanacci stages I and II (P < 0.05). No significant difference was found in age and sex of the patients and locations of the tumor (P > 0.05). Survival analysis showed that the expression status of ezrin, CD44, VEGF, and Campanacci clinical stages of GCTB were positively associated with the survival rate of GCTB patients and negatively associated with ezrin and Campanacci stages of GCTB, indicating that ezrin, CD44, VEGF, and Campanacci clinical stages of GCTB are the independent factors for GCTB.
Conclusions: Ezrin, CD44, and VEGF are over-expressed in GCTB tissue and its adjacent noncancerous tissue samples and may play an important role in the occurrence, invasion, metastasis, and recurrence of GCTB. Measurement of ezrin, CD44, and VEGF expression status may contribute to the judgment of prognosis of GCTB patients.
[1]Kunming Med Univ, Tumor Hosp Yunnan Prov, Affiliated Hosp 3, Dept Orthopaed,Bone & Soft Tissue Tumors Res Ctr, Kunming 650118, Yunnan, Peoples R China.
[2]Kunming Med Univ, Tumor Hosp Yunnan Prov, Dept Pathol, Affiliated Hosp 3, Kunming 650118, Yunnan, Peoples R China.
[3]Kunming Med Univ, Tumor Hosp Yunnan Prov, Affiliated Hosp 3, Dept Radiol, Kunming 650118, Yunnan, Peoples R China.
(8.0+极速模式)